Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 534
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 201–231 of 231 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06530914	A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma	not yet recruiting	Phase 2	30	Lei LiuOTHER	0	Jul 31, 2024	clinicaltrials
NCT06509997	A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma	not yet recruiting	Phase 2	30	Lei LiuOTHER	0